Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-01-21 @ 8:17 PM
Study NCT ID:
NCT04259866
Status:
COMPLETED
Last Update Posted:
2020-02-07
First Post:
2020-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS
Sponsor:
"G Criscuoli" Hospital
Organization:
Study Overview
Official Title:
FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS: An Analysis of Findings Leading to Recall and Work-up in ASL Avellino Screening
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To analyse false positives in breast cancer screening with tomosynthesis versus 2D mammography. The Avellino Breast Tomosynthesis Screening Trial is a observational population-based study that analyze souspicious findings in tomosynthesis slice images.
This study is based on two years screening and tomosynthesis was analzyed by two expert breast radiologists.
This study is based on two years screening and tomosynthesis was analzyed by two expert breast radiologists.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: